Cargando…
SARS-CoV-2 getting into the brain; neurological phenotype of COVID-19, and management by nano-biotechnology
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727447/ https://www.ncbi.nlm.nih.gov/pubmed/36018157 http://dx.doi.org/10.4103/1673-5374.346486 |
_version_ | 1784845022639685632 |
---|---|
author | Kujawska, Małgorzata Mostafavi, Ebrahim Kaushik, Ajeet |
author_facet | Kujawska, Małgorzata Mostafavi, Ebrahim Kaushik, Ajeet |
author_sort | Kujawska, Małgorzata |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9727447 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-97274472022-12-08 SARS-CoV-2 getting into the brain; neurological phenotype of COVID-19, and management by nano-biotechnology Kujawska, Małgorzata Mostafavi, Ebrahim Kaushik, Ajeet Neural Regen Res Perspective Wolters Kluwer - Medknow 2022-06-02 /pmc/articles/PMC9727447/ /pubmed/36018157 http://dx.doi.org/10.4103/1673-5374.346486 Text en Copyright: © Neural Regeneration Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Perspective Kujawska, Małgorzata Mostafavi, Ebrahim Kaushik, Ajeet SARS-CoV-2 getting into the brain; neurological phenotype of COVID-19, and management by nano-biotechnology |
title | SARS-CoV-2 getting into the brain; neurological phenotype of COVID-19, and management by nano-biotechnology |
title_full | SARS-CoV-2 getting into the brain; neurological phenotype of COVID-19, and management by nano-biotechnology |
title_fullStr | SARS-CoV-2 getting into the brain; neurological phenotype of COVID-19, and management by nano-biotechnology |
title_full_unstemmed | SARS-CoV-2 getting into the brain; neurological phenotype of COVID-19, and management by nano-biotechnology |
title_short | SARS-CoV-2 getting into the brain; neurological phenotype of COVID-19, and management by nano-biotechnology |
title_sort | sars-cov-2 getting into the brain; neurological phenotype of covid-19, and management by nano-biotechnology |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727447/ https://www.ncbi.nlm.nih.gov/pubmed/36018157 http://dx.doi.org/10.4103/1673-5374.346486 |
work_keys_str_mv | AT kujawskamałgorzata sarscov2gettingintothebrainneurologicalphenotypeofcovid19andmanagementbynanobiotechnology AT mostafaviebrahim sarscov2gettingintothebrainneurologicalphenotypeofcovid19andmanagementbynanobiotechnology AT kaushikajeet sarscov2gettingintothebrainneurologicalphenotypeofcovid19andmanagementbynanobiotechnology |